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Abstract
Cutaneous beta human papillomavirus (HPV) types appear to be involved in the development of non-melanoma skin cancer
(NMSC); however, it is not entirely clear whether they play a direct role. We have previously shown that E6 and E7
oncoproteins from the beta HPV type 38 display transforming activities in several experimental models. To evaluate the
possible contribution of HPV38 in a proliferative tissue compartment during carcinogenesis, we generated a new transgenic
mouse model (Tg) where HPV38 E6 and E7 are expressed in the undifferentiated basal layer of epithelia under the control of
the Keratin 14 (K14) promoter. Viral oncogene expression led to increased cellular proliferation in the epidermis of the Tg
animals in comparison to the wild-type littermates. Although no spontaneous formation of tumours was observed during
the lifespan of the K14 HPV38 E6/E7-Tg mice, they were highly susceptible to 7,12-dimethylbenz(a)anthracene (DMBA)/12-0-
tetradecanoylphorbol-13-acetate (TPA) two-stage chemical carcinogenesis. In addition, when animals were exposed to
ultraviolet light (UV) irradiation, we observed that accumulation of p21
WAF1 and cell-cycle arrest were significantly alleviated
in the skin of Tg mice as compared to wild-type controls. Most importantly, chronic UV irradiation of Tg mice induced the
development of actinic keratosis-like lesions, which are considered in humans as precursors of squamous cell carcinomas
(SCC), and subsequently of SCC in a significant proportion of the animals. In contrast, wild-type animals subjected to
identical treatments did not develop any type of skin lesions. Thus, the oncoproteins E6 and E7 from beta HPV38
significantly contribute to SCC development in the skin rendering keratinocytes more susceptible to UV-induced
carcinogenesis.
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Introduction
Non-melanoma skin cancer (NMSC) is the most common
cancer in adult fair-skinned populations [1]. Ultraviolet light (UV)
is a key risk factor for the NMSC [2–4]. In addition, it appears that
infectious agent(s) may favor skin carcinogenesis. This is suggested
by the fact that immuno-compromised organ transplant recipients
(OTRs) have a 50–100-fold higher risk of developing NMSC
compared to the general population [5,6] [6] [7] [8]. A sub-group
of cutaneous human papillomavirus (HPV) types, belonging to the
genus beta of the HPV phylogenetic tree, are putative etiological
factors of NMSC [9] [10]. These HPV types were first isolated in
individuals with an autosomal recessive disorder, termed epider-
modysplasia verruciformis (EV). EV individuals are susceptible to
infection by beta HPV types and have a propensity to develop
confluent flat warts, which, in approximately 30% of the cases,
progress to squamous cell carcinomas (SCC) on sun-exposed areas
[9] [10]. Accordingly, DNA from several beta HPV types was
found in a high percentage of precursor lesions, actinic keratoses,
and SCC from OTRs [11] [12] [13]. More recent studies indicate
that beta HPV types are also involved in skin carcinogenesis in the
normal population. Detection of antibodies against the major
capsid protein L1 showed an increased seroreactivity to beta HPV
types in patients with cutaneous SCC in comparison to healthy
individuals [14] [15] [16] [17] [18] [19].
Functional studies have provided further evidence of an
association of beta HPV types with NMSC. Since previous studies
demonstrated the key role in cellular transformation of E6 and E7
oncoproteins from cervical cancer-associated mucosal high-risk
(HR) HPV types, functional investigations on beta HPV types
focused on the characterization of E6 and E7 biological properties.
These studies showed that E6 and E7 from beta HPV types also
displayed transforming capability in in vitro and in vivo experimental
models [10]. E6 from beta HPV types associates with the pro-
apoptotic protein Bak, a member of the Bcl-2 family, promoting its
proteasomal degradation and preventing apoptosis in response to
genomic stress [20] [21]. Studies from our group have shown that
E6 and E7 from beta HPV38 are able to immortalize primary
human keratinocytes [22] [23], similarly to E6 and E7 from the
mucosal HR HPV types. Accordingly, we observed that HPV38 E6
PLoS Pathogens | www.plospathogens.org 1 July 2011 | Volume 7 | Issue 7 | e1002125and E7 expression in these cells leads to the accumulation of
DNp73a, which in turn altersthe p53 transcriptional functions [24].
Tg mouse lines expressing the entire early region of beta HPV8
(E6, E7, E1 E2 and E4 genes) or the E6 gene alone driven by the
K14 promoter, spontaneously developed multifocal skin tumours
and, in approximately 6% of the cases, SCC [25] [26]. In addition,
a single dose of UV rapidly promoted papillomas and SCC
formation [26]. In another study, Tg mouse models for the beta
HPV20 and the benign cutaneous HPV27 were generated, in
which E6 and E7 oncoproteins were expressed as single
polycistronic transcript under the control of the K10 promoter
that is active in the supra-basal differentiated layer of the skin
epidermis [27]. Both Tg models developed skin lesions, including
SCC after exposure to UV irradiation. However, no significant
difference in the skin tumour incidence was observed between
HPV 20 and 27 Tg animals [27]. Based on our in vitro data [22]
[23] [24], we generated K10 HPV38 E6/E7 Tg mice [28]. These
animals displayed hyperplastic and dysplastic patches in the skin
epidermis, but no spontaneous development of skin cancer was
observed during their life span. Application of the two-stage skin
carcinogenesis protocol led to a strong increase in skin tumour
incidence [28]. However, chronic UV irradiation of K10 HPV38
E6/E7 Tg did not lead to development of any type of skin lesions
(Dong et al. unpublished data). The failure of HPV38 E6 and E7
to cooperate with UV irradiation in skin tumour development in
this animal model could be explained by the fact that the viral
genes were expressed in the suprabasal layers of the epidermis,
while in humans beta HPV types infect and initiate the
transcription of the early genes in the basal layer. To explore
this hypothesis, we developed a novel transgenic mouse model for
HPV38 with K14 promoter-driven expression of E6 and E7 in the
basal and proliferative rather then the differentiated compartment
of skin epidermis. Here, we show that ectopic HPV38 E6 and E7
expression in this location strongly enhances the susceptibility to
chemical- and UV-induced carcinogenesis. Most importantly,
chronic UV irradiation of K14 HPV38 E6/E7 Tg mice results in
the development of actinic keratosis-like lesions and SCC, closely
resembling the scenario observed in humans.
Results
Generation and characterization of K14 HPV38 E6/E7-Tg
mice
To evaluate the transforming properties of E6 and E7 from
HPV38 in the proliferative compartment of skin epidermis, we
generated Tg mouse lines expressing the two viral oncogenes
under the control of the human keratin 14 promoter that is active
in the basal layer of the epidermis [29]. A schematic represen-
tation of the transgene construct used is shown in Figure 1A.
Transgene-positive offspring were identified by PCR of tail DNA
using HPV38 specific primers. Two independent Tg mouse lines
(183 and 187) were identified and bred successfully. Viral
oncogene expression was determined by RT-qPCR in different
epithelia, i.e. ear, dorsal skin, tongue, and esophagus. Line 183
expressed higher HPV38 E6/E7 levels than line 187 in all four
examined epithelia (Figure 1B). In each Tg line, HPV38 E6/E7
expression also differed in the four epithelia, being highest in the
dorsal skin and the ear, and comparably low in the tongue and
esophagus (Figure 1B). As expected, no viral oncogene expression
was observed in liver tissue that was included as a negative
control (Figure 1B). No HPV38 E6 and E7 expression was
detected in the same tissues of the wild-type animals (data not
shown).
HPV38 E6 and E7 induce cellular proliferation in the
epidermis of Tg mice
Next, we examined whether HPV38 E6/E7 expression induced
morphological alterations in the epithelia analyzing HE-stained
sections of skin, ear, tongue and esophagus of FBN/V and K14
HPV38 E6/E7-Tg mice. Epidermal hyperplasia in the ear skin
was observed in approximately 5% of 6–8 week-old mice from
both Tg lines, as representatively shown in Figure 2A. These
alterations, although also detected, were much less evident in
dorsal skin (Figure 2A). No significant morphological changes were
observed in epithelia of the esophagus and tongue of both Tg lines
(data not shown).
The morphological alterations observed in ear skin were even
more severe in older animals of lines 183 and 187. Approximately
10–15% of 12-month-old mice from both lines presented dysplasia
and, hyperkeratosis. A representative section is shown in Figure 2B,
where severe dysplastic keratinocytes, hyperkeratosis, endophytic
papillomatous epidermis and a pronounced inflammation could be
observed.
To determine whether the expression of HPV38 E6 and E7
oncoproteins resulted in a deregulation of cellular proliferation, we
next analysed the expression of the proliferation marker Ki-67 by
immunohistochemistry. A significant increase of Ki-67 positivity
was observed in the ear (line 187 Vs FVB/N p,0,001, line 183 Vs
FVB/N p,0.05) and dorsal skin (line 187 Vs FVB/N p,0.001,
line 183 Vs FVB/N p,0.01) epidermis of the two Tg mouse lines
(Figures 3A and 3B). Although morphological changes were not
observed in tongue and esophagus up to the age of 12 months, an
increased Ki-67 index was detected in the epithelia of these tissues
at similar levels to those observed in the ear and dorsal skin (data
not shown). To corroborate these data, we determined the levels of
the positive cell cycle regulator cyclin A in protein extracts from
dorsal skin of wild-type and Tg mice by immunoblotting. Cyclin A
levels were higher in the two Tg mouse lines as compared to the
control animals (data not shown).
Together, these data show that ectopic overexpression of
HPV38 E6 and E7 oncogenes in the basal layer of the mouse
epithelia significantly increased cellular proliferation.
Author Summary
Epidemiological and biological lines of evidence support a
possible involvement of a sub-group of human papillo-
maviruses (HPV), referred to as cutaneous beta HPV types,
in the development of non-melanoma skin cancer (NMSC).
However, their role in carcinogenesis, in particular whether
they synergize with other NMSC risk factors, e.g. UV
irradiation, is still unclear. Here, we describe the generation
of a novel model of transgenic mice (Tg) expressing the
viral oncoproteins E6 and E7 from cutaneous beta HPV38
in the basal layer of the epidermis. We established two
independent lines of HPV38 E6/E7 Tg mice and showed
that they both have an increased susceptibility to develop
squamous cell carcinoma (SCC) in comparison to the wild-
type animals when exposed to chemical carcinogens and
UV irradiation. Most interestingly, we found that UV
irradiation of the Tg animals, promoted the formation of
skin lesions that closely resembled the SCC-precursor
lesions in humans, actinic keratosis and subsequently SCC.
In contrast, we observed that wild-type mice developed
neither actinic keratosis nor SCC when exposed to the
same dose of UV. In conclusion, we present evidence that
supports the role of cutaneous beta HPV types in skin
carcinogenesis.
K14 HPV38 E6/E7 Transgenic Mice
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transgenic mice upon DMBA/TPA treatment
Previous studies reported an increased incidence of papillomas
and SCC in Tg mouse models expressing E6 and E7 from human
or animal papillomaviruses [28] [30] [31] when exposed to
chemical carcinogens. Therefore, we compared tumour suscep-
tibility of wild-type and K14 HPV38 E6/E7 Tg mice in the
multi-stage skin carcinogenesis protocol using DMBA as initiator
and TPA as tumour promoter. Wild-type and Tg animals were
exposed to a single treatment of DMBA followed by repeated
TPA treatments for 20 weeks and subsequent examination for a
further five weeks (Figure 4A). Seven weeks after initiation, 100%
of Tg animals of both lines had developed tumours, while at the
same time wild-type animals showed no skin lesions and became
100% tumour positive three weeks later (Figure 4B). At week 10,
the DMBA/TPA-treated back skin of Tg mice was entirely
covered by tumours, in contrast to the wild-type animals that
developed only a small number of skin lesions (Figure 4C). Due to
the high number of skin lesions including large and multiple SCC
per mouse, all Tg animals of lines 183 and 187 were sacrificed at
week 12 and 14, respectively, while this event was delayed until
week 24 in the wild-type group (Figure 4D). The number of
tumours per animal was significantly higher in the Tg cohort as
compared to the wild-type cohort (Figures 4E). After completion
of the experiment at week 24, histological examination of skin
lesions from all control and Tg mice was performed. Accordingly,
Tg mice of both lines developed SCC more rapidly (Figure 4F)
and at higher incidence than the wild-type mice (Figure 4F).
Representative sections of the tumours at week 10 from control
and Tg animals are shown in Figure 4G. The shown tumour of
the control animal was at an early stage and disruption of
the basement membrane and extension of tumour islands into
the underlying dermis started to be visible (Figure 4G). The
representative sections from Tg animals evidenced SCC charac-
terized by tumour cells with prominent intercellular bridges,
abundant eosinophilic cytoplasm and a large and vesicular
nucleus, plus aberrant accumulations of keratin (keratin pearls)
(Figure 4G, line 183), as well as by irregularly elongated rete pegs
with atypia, defined as vacuolization and nuclear abnormalities of
cells of the stratified squamous epithelium invading the
connective tissue (Figure 4G, line 187).
In summary, these results show that ectopic expression of
HPV38 E6 and E7 in the proliferative compartment of skin
epidermis significantly increases the tumour burden including
papillomas and SCCs in a DMBA/TPA multi-step skin carcino-
genesis approach.
Figure 1. HPV38 E6 and E7 expression in Tg mice. (A) Schematic representation of the K14-HPV38 E6/E7 construct. (B) HPV38 E6 and E7
transcripts are differentially expressed in the epithelia of the two hemizygous Tg mouse lines 183, and 187. Total RNA was extracted from the ear, the
skin, tongue, esophagus, and liver. After preparation of cDNA, E6 and E7 expression was determined by RT-qPCR and normalized towards the
expression level of GAPDH. The data shown in the Figures are the means 6SD of three independent experiments. In each experiment the 187 ear
data is set to 1 and the other values are consequently resized.
doi:10.1371/journal.ppat.1002125.g001
K14 HPV38 E6/E7 Transgenic Mice
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carcinogenicity in K14 HPV38 E6/E7 Tg mice
UV irradiation is a key risk factor for NMSC in humans.
Therefore, we next determined whether K14 HPV38 E6/E7-Tg
mice had an enhanced susceptibility to UVB irradiation. Induction
of DNA damage by UV irradiation normally leads to the
activation of cellular defense mechanisms, mainly mediated by
p53 activation that in turn induces cell cycle arrest prior to the S
phase or apoptosis. The cell cycle block is primarily mediated by
accumulation of the cyclin-dependent kinase inhibitor (CDK)
p21
WAF1, whose gene is positively regulated by p53. Short-term
UVB irradiations of the skin of wild-type mice resulted in an
accumulation of p21
WAF1 in keratinocytes of the basal layer of the
epidermis (Figure 5A). In contrast, this phenomenon was
significantly less evident in the skin of Tg animals (Figure 5A,
right panel, P,0,001 after the third UVB irradiation). In
agreement with the p21
WAF1 expression levels, staining of the
Ki-67 proliferative marker was stronger in the skin of the Tg mice
in comparison to the wild-type animals, even after several doses of
UV irradiation (Figure 5B). These data show that HPV38 E6 and
E7 have the ability to interfere with the regulation of cellular
checkpoints activated by genomic stress, such as UV-induced
DNA damage. Thus, it is likely that HPV38 enhances the
carcinogenicity of UV irradiation.
To evaluate this hypothesis, long-term UVB experiments, in
which FVB/N and Tg mice of lines 183 and 187 were exposed to
multiple and increasing doses of UVB, were carried out
(Figure 6A). After 20–25 weeks of treatment, the majority of
the Tg mice from both lines showed thick, scaly, crusty and
reddish patches in dorsal skin exposed to the UVB light, while no
lesions were observed in wild-type animals (Figure 6B). Histo-
logical analyses revealed that these lesions resemble the
precancerous condition of actinic keratosis. The representative
sections in Figure 6 C show downward prolongations and slight
atypia of the rete pegs without stromal invasion (top panels) and
parakeratosis, acanthosis and broadened elongated rete ridges
with atypia (bottom panels), which are all features of the SCC
precursor, actinic keratosis. In later weeks (25–30), SCC become
visible on the UV-irradiated skin of Tg mice from both lines,
while still no lesions were detected in the control mice (Figure 6D).
Histological analysis of skin sections revealed that more than 80%
of the Tg animals from line 183 developed SCC during the 30
weeks of UV irradiation (Figure 6E). SSC were also detected in
the dorsal skin of line 187 Tg animals, but after a longer latency
period than in line 183 (Figure 6E). The different incidence of
SCC in the two Tg lines tightly correlates with the HPV38 E6
and E7 expression levels (Figure 1B). Representative images of
SSC lesions observed in K14 HPV38 E6/E7 Tg mice after 30
weeks of treatment are shown in Figures 6F. These lesions show
the presence of tumour cells with atypia, horn formation
(Figure 6F, top panels) and tumour cell invasion deep into the
dermis (Figure 6F, bottom panels). In contrast, histological
examination of dorsal skin sections from FVB/N animals at
weeks 30 evidenced only irritation and slight atypia in the
epidermis (Figure 6G).
Together, these data show that HPV38 oncoproteins and UVB
irradiation cooperate in the development of actinic keratosis and
SCC.
Figure 2. Histological analysis of skin specimens from wild-type FVB/N and Tg mouse lines. Representative pictures (original
magnification 406) of HE-stained sections of paraffin-embedded tissues are shown: (A) ear (left panel) and dorsal skin (right panel) of wild-type FVB/N
and Tg mice of the lines 183, and 187. (B) Dysplastic ear skin of K14 HPV38 E6/E7-Tg mice.
doi:10.1371/journal.ppat.1002125.g002
K14 HPV38 E6/E7 Transgenic Mice
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The role of beta HPV types in NMSC is still not conclusively
fully established. Functional studies revealed that beta HPV E6
and E7 proteins, similarly to their homologues from the mucosal
HR HPV types, have the ability to deregulate fundamental cellular
events, such as cell cycle, apoptosis and senescence [20] [21] [22]
[23] [24] [32]. However, despite the functional similarities
between E6 and E7 from beta and mucosal HR HPV types, the
two subgroups of HPV types may induce cancer development by
two distinct mechanisms. It is well demonstrated that the mucosal
HR HPV types play a key role in cancer initiation and
maintenance. In fact, their genomes and E6 and E7 expression
are detected in all cervical cancer cells, and inhibition of the
expression of these viral oncogenes in those cells resulted in a rapid
induction of apoptosis and/or senescence [33]. In contrast,
analyses of skin lesions suggest that beta HPV types may be
involved only at early stage of skin carcinogenesis. This hypothesis
is mainly based on two findings: (i) higher viral load was found in
the SCC-precursor lesion AK than in SCC and (ii) not all cancer
cells resulted positive for beta HPV DNA [34]. Taking into
consideration also the properties of beta HPV oncoproteins to
interfere with the regulation of cell cycle and apoptosis, it is
conceivable to hypothesize that beta HPV E6 and E7 enhance the
carcinogenicity of sunlight, facilitating the accumulation of DNA
damages induced by UV and consequently cancer development.
In normal cells, DNA damage induced by UV irradiation activates
cellular defense processes leading to p53 activation, which in turn
induces cell-cycle arrest or apoptosis to allow repair or elimination
of the damaged cells, respectively. In contrast in beta HPV
infected cells, E6 and E7 expression circumvent the activation of
the cellular defense processes by the UV irradiation, maintaining
the cells in a proliferative state and allowing efficient viral DNA
replication. As a side-effect, these events favour the accumulation
of UV-induced DNA damages and cellular transformation. Due to
the irreversible nature of the UV-induced damages, e.g. mutation
of tumour suppressor genes, the maintenance of the transformed
phenotype may become independent of the viral gene expression.
Our data obtained with K14 HPV38 E6/E7 Tg mice support
this model. Indeed, while in normal mice UV irradiation led to
accumulation of the cell-cycle inhibitor p21
WAF1 and cell cycle
arrest, in the Tg animals these UV-induced phenomena were
strongly inhibited. In addition, although HPV38 E6 and E7
expression per se did not lead to significant morphological
alterations of the epidermis, it strongly facilitated the induction
of SCC by chemical carcinogens or chronic UV irradiation. Most
importantly, SCC development upon chronic UV exposure of
K14 HPV38 E6/E7 Tg mice irradiation was preceded by lesions
that closely resemble actinic keratosis, the precursor lesions of
SCC also observed in humans.
The different susceptibility of the K10 and K14 HPV38 E6/E7
Tg models to UV-mediated carcinogenesis indicates that the
expression of HPV38 E6 and E7 in the basal layer of the epidermis
is an essential event for the development of skin cancer induced by
Figure 3. Analysis of cellular proliferation in the ear and dorsal skin of wild-type and transgenic mice. (A and B, top panels)
Representative pictures of Ki-67 immunostained sections of paraffin-embedded ear skin and dorsal skin from wild-type (FVB/N) and Tg animals (lines
183 and 187). (A and B, lower panels) Quantification of Ki-67-positive cells (brownish signal) in wild-type and Tg epidermis was done by counting 400
hematoxylin-stained cells under 406magnification in 4 different fields of epidermis. Differences between the Ki-67-positive cells in the HPV38 E6/E7
Tg mice (lines 183 and 187) versus the FVB/N mice were statistically significant as determined by Student’s t-test with Welch correction for unequal
standard deviation.
doi:10.1371/journal.ppat.1002125.g003
K14 HPV38 E6/E7 Transgenic Mice
PLoS Pathogens | www.plospathogens.org 5 July 2011 | Volume 7 | Issue 7 | e1002125Figure 4. Tumour burden in wild-type and transgenic mice after DMBA/TPA treatment. (A) Schematic diagram of the initiation and
promotion protocol using DMBA as initiator and TPA as promoter of the two-stage skin carcinogenesis approach. (B) Tumour incidence. Percentage
of animals with skin tumours in the group of FVB/N wild-type and Tg cohorts of lines 183 and 187. Skin tumour formation was recorded each week
until the end of the experiment in week 24 after the beginning of promotion. The difference between the curves of control and transgenic mice is
statistically significant (p,0.0001 determined by logrank test for group data). (C) Representative pictures of dorsal skin from wild-type FVB/N and Tg
mice 10 weeks after the beginning of tumour promotion. (D) Survival curves for DMBA/TPA-treated wild-type FVB/N and Tg animal cohorts of lines
183 and 187. Mice were sacrificed when putative SCC skin lesions reached the size of 15 mm in diameter. The difference between the curves of
control and transgenic mice is statistically significant (p,0.0001 determined by logrank test for group data). (E) Tumour multiplicity. Maximum
number of tumours per animal in the groups of wild-type and Tg lines. The number of tumours was recorded every week. Differences between the
tumour multiplicity in the group of wild-type and Tg lines are statistically significant (control versus line 183, p,0.001; control versus line 187,
p,0.001 as determined by Wilcoxon rank sum test). (F) Incidence of cutaneous SCC in the group of wild-type and transgenic mice. SCC in the
sacrificed wild-type and Tg animals were confirmed by histological analyses. The difference between the curves of control and transgenic mice is
statistically significant (p,0.0001 determined by logrank test for group data). (G) Representative pictures of HE-stained skin lesions from wild-type
K14 HPV38 E6/E7 Transgenic Mice
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that the natural HPV infection and expression of the viral
oncoproteins initiate in the cells of the basal layer. However, it is
also possible that the different behavior of the K10 and K14 Tg
mice after exposure to chronic UV irradiation is due to the
different efficiency of the two keratinocyte promoters, K10 and
K14, in expressing the viral genes. Indeed, K10 Tg animals
express approximately 3–4 lower levels of HPV38 E6 and E7 than
K14 Tg animals (Viariso et al, unpublished data). Thus, additional
studies are required to elucidate the different cancer susceptibility
of Tg mice expressing the viral oncogenes in the basal or supra-
basal layers of the skin. To evaluate the importance of the HPV38
E6 and E7 expression levels in UV-induced carcinogenesis, we are
currently generating a novel K14 Tg line that expresses similar
levels to the K10 Tg animals.
Previous transgenic models used to study the role of beta HPV
in cutaneous cancer express the entire early region (ER) of HPV8
or E6 gene under control of the K14 promoter [25] [26]. The
HPV8 ER and HPV8 E6, showed a remarkable similarity in the
development of skin lesions. Indeed, a single dose of UV led to a
rapid development of papillomas and SCC in both Tg models
[26], which also spontaneously developed benign tumours and, in
a small percentage, SCC [25] [26]. Although these data support
the role of HPV8 in skin carcinogenesis, the HPV8 animal models
do not closely correspond to the situation observed in humans,
where beta HPV infection is normally asymptomatic and SCC
development appears to be strongly associated with chronic UV
exposure. The difference observed in K14 HPV8 E6 or HPV8 ER
and K14 HPV38 E6/E7 Tg mice may simply reflect the more
aggressive properties of the oncoproteins from HPV8 in
comparison to HPV38. However, studies in in vitro experimental
models do not support this hypothesis. In fact, HPV8 E6 and E7
displayed lower in vitro transforming activities when compared to
the oncoproteins from the mucosal HR HPV types [35] [36] [37].
(FVB/N) and K14 HPV38 E6/E7-Tg mice (lines 183 and 187) collected after 10 weeks of chemical carcinogens treatment (original magnification 56).
Magnified areas are shown in the right panels.
doi:10.1371/journal.ppat.1002125.g004
Figure 5. p21
WAF1 and Ki-67 levels in the skin of wild-type and K14 HPV38 E6/E7-Tg mice after UVB irradiation. Wild-type and Tg
animals were irradiated up to 5 times as described in Materials and Methods. 24 hours after the last irradiation, mice were sacrificed and skin tissue
was analyzed by immuno-histochemistry. (A) Representative Ki-67 and p21
WAF1 immunostainings of skin from wild-type and Tg mice non-exposed
(06) or four time (46) exposed to UVB. (B) Quantification of p21
WAF1 and Ki-67-positive cells in skin of wild-type and Tg mice before and after UVB
irradiation. The percentage of p21
WAF1 and Ki-67-positive cells in the epidermis was determined as described in the legend of Figure 3. The
differences between the percentages of p21
WAF1 or Ki-67-positive cells in the HPV38 E6/E7 Tg mice (lines 183 and 187) versus the FVB/N non-Tg mice
are statistically significant (*=p,0.05, **=p,0,001) as determined by Student’s t-test.
doi:10.1371/journal.ppat.1002125.g005
K14 HPV38 E6/E7 Transgenic Mice
PLoS Pathogens | www.plospathogens.org 7 July 2011 | Volume 7 | Issue 7 | e1002125Figure 6. Tumour burden in wild-type and K14 HPV38 E6/E7-Tg animals upon UVB irradiation. (A) Schematic diagram of the
experimental procedure of long-term UVB irradiation. (B) Representative pictures of dorsal skin from wild-type FVB/N and HPV-Tg mice exposed to
UVB light for 24 weeks. (C) Representative pictures of HE-stained actinic keratosis affected epidermis (AK) from K14 HPV38 E6/E7-Tg mouse lines 183
and 187 after 24 weeks of irradiation (original magnification 106). Magnified areas are shown in the right panels. (D) Representative pictures of dorsal
skin from wild-type FVB/N and HPV-Tg mice exposed to UVB light for 29 weeks. (E) Percentage of animals with skin SCC in wild-type and Tg cohorts of
lines 183 and 187. Tumour formation was monitored each week until the end of the experiment in week 30 after start of treatment, and confirmed by
histological analyses after sacrifice of the animals. The difference between the curves of control and transgenic mice is statistically significant
(p,0,0001 determined by logrank test for group data). (F) Representative pictures of HE-stained of SCC sections (SCC) from K14 HPV38 E6/E7-Tg
mouse lines 183 and 187 after 30 weeks of UVB irradiation (original magnification 56). Magnified areas are shown in the right panels. (G)
Representative pictures of HE-stained epidermis from wild-type FVB/N mice after 30 weeks of UVB irradiation (original magnification 106). Magnified
area is shown in the right panel.
doi:10.1371/journal.ppat.1002125.g006
K14 HPV38 E6/E7 Transgenic Mice
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human keratinocytes [22] [23], to deregulate p53 functions [24]
and up-regulate the expression of the catalytic subunit of the
telomerase hTERT [23] [32], all features shared with E6 and E7
from the mucosal HR HPV types. The different phenotype of the
K14 HPV8 ER and K14 HPV38 E6/E7 Tg mice could be
explained by a different number of integrated copies of HPV DNA
and expression levels of the viral oncoprotein in the two Tg
models. In addition, regarding the K14 HPV8 ER Tg mice, it is
likely that the product of other early genes cooperate with E6 and
E7 in promoting cancer development. For instance, HPV8 E2 has
been shown to display transforming properties in in vitro and in vivo
models [38] [39]. However, as already described above, K14
HPV8 E6 and HPV8 ER Tg mice showed a very similar
phenotype, indicating that E2 may play a less important role than
E6 in the induction of skin lesions [25] [26]. Thus, it is not yet
clear why these two animal models, K14 HPV8 E6/E7 and K14
HPV38 E6/E7, showed different phenotypes.
Independently of these differences, both Tg animal models
provided evidence for a cooperation of the beta HPV types and
UV irradiation in skin carcinogenesis. Interestingly, the cooper-
ation of infectious agents and environmental factors in carcino-
genesis has also been shown in previous studies on bovine
papillomavirus type 4 (BPV4). In cows grazed on grass or fed on
hay, BPV4 infection leads to development of papillomas of the
upper gastrointestinal tract that are spontaneously rejected in a
relative short time, e.g. 12 months. In contrast, in cows kept on a
diet of bracken fern, BPV4-induced papillomas persist and
progress to cancer. This phenomenon is explained by the fact
that bracken fern contains several molecules that induce
immunosuppression or mutagenesis. These immunosuppressants
favour the persistence of the viral infection, while mutagenic
substances, e.g. quercetin, promote DNA damage, rendering the
infected cell more susceptible to transformation. Thus, studies on
beta HPV types and BPV4 underline the importance of
environmental factors in virus-mediated carcinogenesis.
Methods
Plasmid construction and generation of Tg mice
The E6 and E7 ORFs of HPV38 were amplified by polymerase
chain reaction (PCR) using as template the entire HPV38 genome,
and were cloned in a pGEM-3Z vector containing the K14
promoter, a b-globin intron 2, and the K14 polyadenylation
sequence (kindly provided by Professor Herbert Pfister, University
of Cologne). The complete insert was isolated (see Figure 1A) and
microinjected, at a concentration of 3 ng/ml, into the pronuclei of
fertilized eggs to generate Tg mice, as described previously [40].
HPV38 E6 and E7 positivity was determined by PCR using
specific primers located in the 59 (59-ATG GAA CTA CCA AAA
CCT CA-39) and 39(59-TTA TCG TCC GCC ATT GCG-39)
regions of the E6 and E7 genes, respectively.
We identified two lines (183 and 187) of HPV38 E6/E7 Tg
mice in a FVB/N genetic background. Experiments were
performed with K14 HPV38 E6/E7 transgenic lines 183
tg/wt,
and 187
tg/wt and wild-type FVB/N littermates. The animals were
kept in the central animal unit of the DKFZ, Heidelberg,
Germany, under an artificial day/night rhythm and were fed
Kliba 3437 standard food pellets and water ad libitum if not stated
otherwise.
Ethics statement
All experiments described in this study were performed in strict
accordance to federal law and the standard ethical guidelines
(NIH, 1985; European Communities Directives, 1986 86/609/
EEC) and approved by local government authorities (Regierung-
spra ¨sidium Karlsruhe, Germany) under license G162-08. Animal
treatments, e.g. UV irradiation, were performed under Sevorane
anesthesia, and all efforts were made to minimize suffering.
Total RNA isolation and reverse transcription PCR
analyses
Total RNA was isolated from dorsal skin, ear, esophagus,
tongue, and liver of 6–8-week-old Tg animals using the Qiagen
RNeasy isolation kit (Quiagen, Hilden, Germany). cDNAs were
synthesized from 1 mg of total RNA using the M-MLV reverse
transcriptase (Invitrogen, Darmstadt, Germany), 18 bp length
polydT were used as primers. Quantitative reverse transcription
PCRs (RT-qPCRs) were performed in a 25 ml mixture containing
1 ml of 1:5 diluted cDNA and SYBR-green master mix (SA
bioscience, Frederick, Maryland) with specific HPV38 E6 primers
(59-TGC TTA TGC TTC TGC TCA ATA TG-39 and 59-GTC
TGT TGC TCC ACC TGT TC-39) or mouse GAPDH primers
to amplify a housekeeping gene as internal control (59 –AAG AAG
GTG GTG AAG CAG GCA TC-39 and 59-CGA AGG TGG
AAG AGT GGG AGT TG-39), using an Applied Biosystems 7300
machine (Applied Biosystems, Darmstadt, Germany). The fluo-
rescence threshold value was calculated using the SDS analysis
software from Applied Biosystems.
Histological and immunohistochemical analysis
Tissue samples from 6–8-week-old mice were fixed in 4%
formaldehyde for 24 h at room temperature, and embedded in
paraffin. Five mm sections were either stained with hematoxylin/
eosin (HE) or used for immunostaining using anti Ki-67 (1:200)
(MM1, Novocastra, Wetzlar, Germany) or p21
WAFI antibody
(1:250) (556431, BD Pharmingen, Heidelberg, Germany). Staining
was performed using biotin-labeled goat anti-mouse immunoglob-
ulin G and ABC agent from M.O.M kit (Vector Peterborough,
UK). The percentages of positive cells were determined by
counting 400 hematoxylin-stained cells under 406 magnification
in four different fields of the epithelium.
For histological analyses, tissue samples from wild-type and Tg
mice were fixed in 4% formaldehyde for 24 h at room
temperature, and embedded in paraffin and five mm sections
were stained with hematoxylin/eosin (HE).
UVB treatments
UVB irradiation was performed with a Bio-Spectra system
(Vilber Lourmat, Marne La Vallee, France) at a wavelength of
312 nm. Each animal was anesthetized with 3% Sevorane
(Abbott, Wiesbaden, Germany) in an inhalation anesthetizer
(Provet, Lyssach, Switzerland) and placed in a covered compart-
ment with an upper square opening (362 cm) at a distance of
40 cm from the UVB lamp. To determine the impact of viral
proteins on UV-induced checkpoints, 7-week-old mice where
shaved on the dorsal skin, and irradiated up to 5 times in a row,
maximum 2 times a day, with UVB at 450 mJ/cm
2. Twenty-four
hours after the last dose, mice were sacrificed and skin sections
stained as described above.
To study UV-induced carcinogenesis, groups of n=30 7-week-
old female FVB/N wild-type or transgenic mice of lines 183
tg/wt
and 187
tg/wt were shaved on the dorsal skin with electric clippers
and irradiated 3 times a week for 20 weeks with increasing doses of
UVB, starting from 120 mJ/cm
2 to a final dose of 450 mJ/cm
2,
with a constant weekly increase to allow skin thickening. For the
following 10 weeks mice were irradiated 3 times a week with
K14 HPV38 E6/E7 Transgenic Mice
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2. The tumour incidence (tumour bearers/group) was
recorded weekly. Tumours were identified first macroscopically
and by histological diagnosis. After thirty weeks, or earlier if the
tumour reached the ethically allowed maximal size, the animals
were sacrificed and HE-stained sections of dorsal skin served for
histological diagnosis.
Initiation-promotion experiments
Five weeks after birth, mice were shifted to Altromin 1324 diet.
For epicutaneous applications of initiator, the dorsal skin was
shaved with electric clippers 7 days before treatment. Experimen-
tal groups of n=20 (acetone/acetone) or n=23–27 (7,12-
dimethylbenz-anthracene (DMBA)/12-O-tetradecanoyl-phorbol-
13-acetate (TPA)) 7-week-old female FVB/N wild-type or
transgenic mice of lines 183
tg/wt and 187
tg/wt were initiated either
by a single epicutaneous application of 0,2 ml acetone or
400 nmol DMBA in 0.2 ml acetone. Beginning one week later,
the mice were treated each twice weekly with 0.1 ml acetone or
with 5 nmol TPA in 0.1 ml acetone for maximally 20 weeks.
Papilloma and carcinoma development was monitored up to week
24 without further treatment. Animals were monitored every three
days throughout the experiment. The tumour incidence (tumour
bearers/survivors in percent) and yield (number of tumours/
survivors) were recorded weekly. Tumours were first identified
macroscopically and later on by histological diagnosis.
Statistical analysis
Percentages of positive cells in immunostained sections were
compared between the different lines with the Student’s t-test and
statistical analysis were performed with GraphPad Prism (version
4.00, GraphPad Software Inc., La Jolla, CA, USA) Time to first
tumor, time to death and time to SCC were displayed with
Kaplan-Meier plots or 1- Kaplan-Meier plots. Animals sacrificed
for analysis were considered censored. Time to first tumor, time to
death and time to SCC were compared between the different
groups with the logrank test. For the CoCa experiment, maximal
tumor burden was determined for every animal and groups were
compared with the Wilcoxon rank sum test. Statistical analyses
were performed with R (version 2.12.0, Copyright (C) 2010 The R
Foundation for Statistical Computing) and SAS (Version 9.2, SAS
Institute Inc., Cary, NC, USA).
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